Analysis of whole-exome sequencing data from III:1 and III:2 did not identify pathogenic variants in genes previously associated with EDS (including AEBP1, not tested in the above panel), and revealed 43 heterozygous variants shared by the two affected individuals, that were not ruled out by our pipeline. This evidence concerns the gene AEBP1 and Ehlers-Danlos syndrome.